staceywhite, Author at European Medical Journal - Page 14 of 195

EuroPCR 2025: Is the Future of Severe Pulmonary Embolism Interventional?

Experts from various fields share insights on pulmonary embolism (PE) treatment, including.A focus on catheter-directed thrombolysis and…

Spotlight on CIDP

Exploration of key data on chronic inflammatory demyelinating polyneuropathy (CIDP) presented at EHA 2025. Post-hoc analysis of the ADHERE…

Distinct Resting-State EEG Biomarkers Predict Amyloid Status and Alzheimer’s Conversion

Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and stratification…

Review of the 11ᵗʰ Congress of the European Academy of Neurology (EAN)

THE SUMMER solstice this year was celebrated by many neurologists in the charming city of Helsinki, Finland, as they came together for EAN…

How Clinicians Can Encourage People with Multiple Sclerosis

Multiple sclerosis (MS) is a complex, lifelong neurological condition that presents with unpredictable symptoms, progressive disability…

The New McDonald Criteria: Faster and Improved Diagnosis of Multiple Sclerosis

THE 2024 REVISED McDonald Criteria for multiple sclerosis (MS) diagnosis were explained in detail during a joint session between the EAN…

Third-Party Reports of SUDEP in Adults and Older Adolescents

Sudden unexpected death in epilepsy (SUDEP) is the most significant complication of epilepsy, with an incidence of 1.2 per 1,000…

EAN 2025: What’s New in Neurology Guidelines?

With a mission to standardise and elevate the quality of neurological care across Europe, EAN 2025 introduced updates and new guidance in…

Glymphatic Dysfunction in Motor Neurone Disease Phenotypes

Converging evidence supports a key pathogenic role of the glymphatic system in the accumulation of pathological aggregates in several…

Rethinking Mild Asthma in Primary Care

BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate exacerbation risk…